Sensorita’s mission is to help waste companies cut costs and emissions by providing cutting-edge analytics. Insight into waste trends and detailed information about every single waste container enables more efficient waste management through better planning, logistics and waste collection. The potential is huge and we are just getting started.

Octo Ventures, based in Oslo, Norway, is an incubator that initiates, invests in, and develops companies together with external co-founders. Based on investment criteria that have proved to deliver superior returns, we have developed a proprietary algorithm that generates high-potential ideas. Our methodology combines best practices within innovation, product development, and business design to accelerate the process from concept development to MVP and commercial launch.

Supported by Bodø communes næringsfond and Innovasjon Norge; in the Sprint 1 phase of creating a mobile application catering to a worldwide multilingual user base and a commercial customer. The goal is to establish a profitable and expandable product range that will enhance learning by the discovery in a way that triggers competition, exercise, and a quest for learning more from already available knowledge both in the local area and while traveling. The founder is an operational international airline professional with a sizable network, catering to a viral-based initial expansion model.

Utdannet.no er et av Norges raskest voksende e-læringsselskaper. Vi har 18 000 registrerte medlemmer og våre nettkurs har over 1 million visninger. Vi har kunder fra bedrifter som: Adresseavisen, Amedia, Ark Bokhandel, CDON, Hegnar, IKEA, NAV, Nordea, NRK, Oslo kommune, Oslo Spektrum, Storebrand, Teknisk Ukeblad, Telenor, Utdanningsforbundet og VG.

People find going to the optician frustrating and it is something they tend to delay as long as possible. Pain points include complicated, non-transparent pricing, lack of understanding about lenses and the options available, and insecurity when choosing glasses. Our mission is to remove these pain points and provide a more relevant modern alternative to the traditional optician. Our vertical concept allows us to offer high-quality designer eyewear at affordable prices - enabling people to build a collection of eyewear to meet the needs of their individual lifestyles. We are currently generating 14 million Nok in sales per year through our 5 Kaibosh stores (Oslo, Bergen, Copenhagen, Frederiksberg & Aarhus), e-commerce operation, and wholesale distribution channels.

Miksapix Interactive is an indie app development company that produces interactive storytelling apps for kids with Sami folk tales and legends. Miksapix Interactive is a production company that specializes in developing apps and games. The company also sells digital products and services in a wide range and focuses on the utilization of new technology and creating good user experiences in the borderland between art, technology, and design.

I started UVanTECH based on my experience in Automation and water treatment systems for the public, fish farming, offshore, and Ballast water treatment systems. There is now an international requirement that all ships, in commercial operation, must install Ballast water treatment systems. In UVanTECH we make UV powers that require 50% less space and reduce power consumption by 25% The product is patented and tested according to international marine standards. A contract is signed whit a major actor in the Ballast water market. The Business area is: - UV Powers for rough environments - Consultant and service for UV Systems, Filters, Flowmeters, Flow and Pressure Control valves. - Ballast water treatment systems for ships (BWT) - Fish Farms and Aquaculture - General Water treatment

Upnode AS delivers solutions to ensure the performance, availability, and quality of your websites and services to ensure that your online presence and digital assets meet modern expectations and requirements. Full kontroll på én eller hundre nettsider Løsningen som ivaretar det tekniske ved dine nettsider, slik at du kan fokusere på verdiskaping for deg eller dine kunder

The Lyfstone diagnostic tests are ready for distribution to pilot clients, and will have a full scale, international commercial launch Q3-2018 Artificial joints are one of the most important medical successes of our time Unfortunately this success has created a new problem – these implants loosen over time and have to be revised Currently, diagnosis of loosening is unclear and the revision surgeries are both complex and costly Lyfstone gives surgeons and patients a clear and objective diagnostic tool for determining the need to proceed with a revision procedure or not

Myldring skaper møteplasser. Vi er arrangører, regissører, tekniske tilretteleggere for møteplasser der ideer og kunnskap er fellesnevneren. Målet vårt er å legge tilrette for flere tankevekkere og interessante koblinger. Noen av møteplassene arrangerer vi selv. Som Stormkast, konferansen om morgendagens industrielle muligheter. Eller Substans - den ettertenksomme møteplassen om teknologi, landbruksteknologi-samlingen Beit. Og innovasjonsmønstringen NuWave.I tillegg påtar vi oss ansvar for andres arrangement. Å være godt vertskap og skape gode rammer er et fag. Det å få teknikken til å fungere kan være avgjørende. Å lage gode video-opptak kan mangedoble verdien av den kunnskapen som formidles fra scenen. Vi jobber kollaborativt. Vi tror på gode partnerskapsmodeller. Derfor jobber vi sammen med flinke underleverandører. Vi prøver å skape sponsormodeller og partnerskap som skaper vinn-vinn. Målet vårt er å skape nettverk. Få koblet sammen ulike fagmiljøer. Løfte blikket. Gjøre verden litt mer interessant.

Bookify is a nationwide search portal targeted to anyone planning meetings, events, conferences, kick-offs, and much more. With different search criteria and filters, you`ll have simple access to meetings and conference venues adapted to your standards. Quick and Easy. Bookify makes it easy to find meeting rooms, function rooms and conference rooms. We also simplify the process for people who have a suitable premise they want to rent out but do not know how to proceed. In the app you can quickly find premises near you, it is easy to find the premises that have the facilities you are looking for and payment is done seamlessly right in the app! The app uses geolocation so that you can quickly book the premises you are looking for. At the same time, you can also do more advanced searches to book ahead of time. You have a full overview of upcoming meeting rooms, payment history and receipt archives. In addition, you can add premises you use often as favorites to make the booking process even easier and faster!

Nøtteblanderen er en lokal matprodusent som produserer og pakker produkter av ypperste kvalitet innen nøtter, frukt, frø, ris, bønner, kokos, krydder, urter, sjokolade, snacks og te. Nøtteblanderen har et moderne produksjonsanlegg på Helsfyr/Ensjø i Oslo som benytter utelukket norsk arbeidskraft som gir lokale arbeidsplasser i Norge.

What is Between? The process of moving out of your home and into a new one can be one of the greatest stresses of life. To the average person, it’s an expensive and overwhelming process that involves listmaking, phone calls with real estate agents, taking time off from work, packing, heavy lifting, buying takeaway dinners, cleaning, and so on. Have you ever wondered why there’s no app that could help alleviate the pain points of moving? We have. That’s why we founded Between – Norway’s first moving platform. Between is a digital service that revolutionizes the moving process with technology, innovation and the ability to understand needs. To the average person, it means less stress and more control. To electrical and insurance companies, who each year lose thousands of customers due to address changes, it will lead to a lower churn rate and a higher return on investment. To real estate agents and developers, we will provide added value to a much smoother customer journey. What we have achieved We are a small group of entrepreneurs who have founded several successful businesses together. One of which is an online change of address service, a pilot company which has helped us research the moving market for the last two years – with over 50.000 registered customers in Norway and Sweden. Between is the next step. Not just for us, but for the millions of people out there who are about to begin a new life in a new home. We’re doing this because we know that if we can make moving easier, we will also make life easier.

Movel AS provides support and invoicing services for AC charging systems. We specialize in systems that provide normal charging for long-term and overnight parking. Movel wants to contribute to a more environmentally friendly life. Therefore, all power in Movel's charging systems provides renewable energy.

Biozep is discovering and developing first-in-class drug products for the treatment of severe eye diseases which can lead to vision loss and where it is a high unmet medical need. Biozep has discovered novel drug substances based on bioactive lipids which modulate central pathways involved in the pathogenesis of eye diseases. Targets and biomarkers are identified based on a system biology approach combined with in-depth knowledge about bioactive lipids, their endogenous synthesis and mechanisms of action. Biozep has made a prototype drug product based on our lead compound for topical administration and the product will be tested in animal models in 2018. Our goal is to start clinical studies in 2020. Biozep is a company depending on both internal and external resources. Biozep has established its own laboratory in Oslo in order to do synthesis, purification, quality control and chemical development in-house. The biological testing of the drug substances is performed in collaboration with carefully selected contract research organizations both in Europe and the USA. In order to reach the market as fast as possible and to reduce risk, Biozep will seek strategic partnerships early in the drug development phase. Biozep seeks partners with complementary competence and with resources to conduct clinical trials and with market access. We are already in dialogue with potential partners and hope to sign an agreement in 2018-19.